The purpose of this work was to review and synthesise the evidence on the comparative
effectiveness of neutralising monoclonal antibody (nMAB) therapies in individuals exposed …

Millions of people worldwide have chronic kidney disease (CKD). Affected patients are at
high risk for cardiovascular (CV) disease for several reasons. Among various comorbidities …

Background Hyperimmune immunoglobulin (hIVIG) contains polyclonal antibodies, which
can be prepared from large amounts of pooled convalescent plasma or prepared from …

Seven coronaviruses are known to cause infection/disease in humans. Of these, human
coronavirus (HCoV)-229E and HCoV-NL63 are alphacoronaviruses (α-CoVs), whereas …

ABSTRACT Introduction On 26 November 2021, the World Health Organization's Technical
Advisory Group on SARS-CoV-2 Virus Evolution designated PANGO lineage B. 1.1. 529 a …

Background Patients with myasthenia gravis (MG) are potentially prone for a severe COVID-
19 course, but there are limited real-world data available on the risk associated with COVID …

Abstract Background: While Molnupiravir and Paxlovid have recently been approved for use
in some countries, there are no widely available treatments for COVID-19, the disease …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can induce mild
to life-threatening symptoms. Especially individuals over 60 years of age or with underlying …

Dear Editor, We read with great interest the article in this journal by Luo et al. regarding the
use of tocilizumab in patients with COVID-19 infection 1. As the global cases of COVID-19 …

Mesenchymal Stem Cells (MSCs) are being investigated as a treatment for a novel viral
disease owing to their immunomodulatory, anti-inflammatory, tissue repair and regeneration …